Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from Teleflex ( (TFX) ).
Teleflex held its 2026 annual meeting of stockholders on May 15, 2026, at which shareholders voted on the election of seven directors to one-year terms, an advisory resolution on executive compensation and the ratification of PricewaterhouseCoopers LLP as the independent auditor for 2026. All seven director nominees received strong shareholder support, the say-on-pay proposal passed with a substantial majority and the auditor ratification was approved, signaling continued investor backing for the company’s leadership, compensation practices and financial oversight.
These voting outcomes reinforce stability in Teleflex’s corporate governance structure and suggest shareholders remain broadly aligned with the board’s strategic direction. The approval of executive pay and reappointment of PricewaterhouseCoopers LLP may bolster confidence among investors and other stakeholders in the company’s management and financial reporting processes.
The most recent analyst rating on (TFX) stock is a Hold with a $143.00 price target. To see the full list of analyst forecasts on Teleflex stock, see the TFX Stock Forecast page.
Spark’s Take on TFX Stock
According to Spark, TipRanks’ AI Analyst, TFX is a Neutral.
The score is held back primarily by deteriorated recent profitability and a negative P/E that reflects pressured earnings. Offsetting that, technicals are supportive (price above key moving averages with positive MACD), cash flow remains positive, and management reaffirmed 2026 growth/EPS guidance with planned buybacks and debt reduction—though margin pressure, separation-related stranded costs, and divestiture timing/regulatory risks remain key swing factors.
To see Spark’s full report on TFX stock, click here.
More about Teleflex
Teleflex operates in the medical technology industry, supplying medical devices and related healthcare equipment to hospitals, clinics and other care providers worldwide. The company focuses on developing and marketing specialty devices used in critical care and surgical applications, targeting both domestic and international healthcare markets.
Average Trading Volume: 900,283
Technical Sentiment Signal: Hold
Current Market Cap: $5.77B
Find detailed analytics on TFX stock on TipRanks’ Stock Analysis page.